source
- Eli Lilly sues six U.S. entities over illegal retatrutide sales, urges broader crackdownEli Lilly announced legal action against six U.S. entities accused of selling its experimental obesity drug retatrutide on the black market. The lawsuits target compounding pharmacies, medical spa…
- Lilly sues over black-market retatrutide; Neurocrine's new obesity drug linked to patient deathsEli Lilly has filed six lawsuits against U.S. companies it says are illegally selling black-market versions of its experimental obesity drug retatrutide. The company alleges the defendants are dist…